Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-26 @ 12:45 AM
Study NCT ID:
NCT00801060
Status:
TERMINATED
Last Update Posted:
2015-10-02
First Post:
2008-12-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2010-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-12-02
First Submit QC Date:
None
Study First Post Date:
2008-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-10-02
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-09-17
Last Update Post Date:
2015-10-02
Last Update Post Date Type:
ESTIMATED